Over the past 12 months, 0 insiders at ZIOPHARM ONCOLOGY INC filed 0 open-market SEC Form 4 transactions on ZIOP: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 22, 21 | Groot Eleanor DeEVP, Operations | SELL | 20.1K | $1.27 | $26K |
| Nov 17, 21 | Kevin S. Boyle Sr.Chief Executive Officer | BUY | 9.1K | $1.40 | $13K |
| Nov 16, 21 | Kevin S. Boyle Sr.Chief Executive Officer | BUY | 884 | $1.40 | $1K |
| Sep 29, 21 | Jaime VieserDirector | BUY | 100.0K | $1.91 | $191K |
| Sep 2, 21 | Heidi HagenDirector | BUY | 23.8K | $1.76 | $42K |
| Sep 2, 21 | Robert W PostmaDirector | BUY | 54.5K | $1.73 | $94K |
| Sep 1, 21 | James HuangDirector | BUY | 100.0K | $1.71 | $171K |
| Sep 1, 21 | Holger WeisDirector | BUY | 50.0K | $1.83 | $92K |
Over the past 12 months, insiders at ZIOPHARM ONCOLOGY INC filed 0 open-market purchases worth $0 and 0 sales worth $0 on ZIOP, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market ZIOP insider purchase in our data was $191K by Jaime Vieser, Director, filed on Sep 29, 21.
0 different insiders at ZIOPHARM ONCOLOGY INC filed open-market SEC Form 4 transactions on ZIOP over the last 12 months.
InsiderTape plots every ZIOP insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ZIOPHARM ONCOLOGY INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →